Gene therapy for central nervous system injury: The use of cationic liposomes: An invited review

Journal of Neurotrauma

Volumn 14, Issue 5, 1997, Pages 281-297

  Yang, K ^a   Clifton, G L ^a   Hayes, R L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

CNS injury; Gene transfer; Liposome; Neurotrophin

Indexed keywords

BETA GALACTOSIDASE; LIPOSOME; NEUROTROPHIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DNA PROTEIN COMPLEX; ENDOCYTOSIS; GENE INDUCTION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; NERVOUS SYSTEM INJURY; NEUROFILAMENT; NONHUMAN; REVIEW; TRANSGENE;

EID: 0030956111     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.281     Document Type: Review

References (144)

1. AKLI, S., CAILLAUD, C., VIGNE, E., STRATFORD-PERRICAUDET, L.D., POENARU, L., PERRICAUDET, M., KAHN, A. and PESCHANSKI, M.R. (1993). Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genetics 3, 224-228.
2. ALDERSON, R.F., ALTERMAN, A.L., BARDE, Y.A., and LINDSAY, R.M. (1990). Brain derived neurotrophic factor increases survival and differentiated functions of rat sepral cholinergic neurons. Neuron 5, 297-306.
3. ALETTA, J.M., LEWIS, S.A., COWAN, N.J., and GREENE, L.A. (1988). Nerve growth factor regulates both the phosphorylation and steady-state levels of microtubule-associated protein 1.2 (MAP 2). J. Cell. Biol. 106, 1573-1581.
4. ALETTA, J.M., TSAO, H., and GREENE, L.A. (1990). How do neurites grow? Clues from NGF-regulated cytoskeletal phorphoproteins. In: Trophic factors and the nervous system. Horrocks, L.A. (Eds.) New York: Raven Press, pp. 203-218.
5. BAJOCCHI, G., FELDMAN, S.H., CRYSTAL, R.G., and MASTRANGELI, A. (1993). Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Gen. 3, 229-234.
6. BALAZSOVITS, J.A., MAYER, L.D., BALLY, M.B., CULLIS, P.R., MCDONELL, M., GINSBERG, R.S., and FALK, R.E. (1989). Analysis of the effect of liposome encapsulation on the vesicent properties, acute and cardiac toxicities, and antitumor efficacy of doxorubucin. Cancer Chemother. Pharmacol. 23, 81-86.
7. BECKER, Y., and DARAI, G. (1995). Gene transfer by viral vectors for gene therapy. J. Mol. Med. 73, 103-105.
8. BERNS, K.I., and GIRAUD, C. (1995). Adenovirus and adeno-associated virus as vectors for gene therapy. Ann. N.Y. Acad. Sci. 772, 95-104.
9. BETZ, A.L., YANG, G.Y., and DAVIDSON, B.L. (1995). Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 15(4), 547-551.
10. BREAKEFIELD, X.O., and DELUCA, N.A. (1991). Herpes simplex virus for gene delivery to neurons. New Biol. 3, 203-218.
11. BREAKEFIELD, X.O. (1993). Gene delivery into the brain using virus vectors. Nature Gen. 3, 187-188.
12. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
13. CAO, L., ZHENG, Z.C., ZHAO, Y.C., JIANG, Z.H., LIU, Z.G., CHEN, S.D., ZHOU, C.F., and LIU, X.Y. (1995). Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA-lipofectin complex. Hum. Gene Ther. 6, 1497-1501.
14. CAPECCHI, M.R. (1980). High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22(2), 479-488.
15. CAPLEN, N.J., ALTON, E.W.F.W., MIDDLETON, P.G., DORIN, J.R., STEVENSON, B.J., GAO, X., DURHAM, S.R., JEFFERY, P.K., HUDSON, M.E., COUTELLE, C., HUANG, L., PORTEOUS, D.J., WILLIAMSON, R., and GEDDES, D.M. (1995). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1(1), 39-46.
16. CHEN, K.S., and GAGE, F.H. (1995). Somatic gene transfer of NGF to the aged brain: Behavioral and morphological amelioration. J. Neurosci. 15, 2819-2825.
17. CHENG, P.W. (1996). Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin. Human Gene Ther. 7, 275-282.
18. CHIOCCA, E.A., CHOI, B.B., CAI, W., DETUCA, N.A., SCHAFFER, P.A., DIFIGLIA, M., BREAKEFIELD, X.O., and MARTOZA, R.L. (1990). Transfer and expression of the LacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biologist 2, 739-746.
19. CHOI-LUNDBERG, D.L., J LIN, Q., CHANG, Y.-N., CHIANG, Y.L., HAY, C.M., MOHAJERI, H., DAVIDSON, B.L., and BOHN, M. (1997). Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275(7), 838-841.
20. COUNE, A. (1988). Liposomes as drug deliver; system in the treatment of infectious diseases: Potential applications and clinical experience. Infection 16, 141-147.
21. CULVER, K.W., RARN, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
22. CURIEL, D.T., AGARWAL, S., WAGNER, E., and COTTEN, M. (1991). Adenovirus enhancement of transferin-polylusine-mediated gene delivery. Proc. Natl. Acad. Sci. USA 88, 8850-8854.
23. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genetics 3, 219-223.
24. DEBS, R., HEATH, T., and PAPAHADJOPOLOUS, D. (1987). Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration. Biochem. Biophys. Acta 901, 183-190.
25. DEKKER, A.J., RAY, W.J., THAL, L.J., and GAGE, F.H. (1994). Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basilis magnocellularis. Neuroscience 60, 299-309.
26. DEKKER, A.J., and THAT, L. (1992). Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: Dose requirements. Brain Res. 584, 5563.
27. DELLIG, C., and SELIGER, B. (1990). Gene transfer into brain tumor cell lines: reporter gene expression using various cellular and viral promoters. J. Neurosci. Res. 26(3), 390-396.
28. DIXON, C.E., TAFT, W.T., and HAYES, R.L. (1993). Mechanisms of mild traumatic brain injury. J. Head Trauma Rehab. 8(3), 21-32.
29. DIXON, C.E., FLINN, P., BAO, J., VENYA, R., and HAYES, R.L. (in press). Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp. Neurol.
30. DOLL, R.F., CRANDALL, J.E., DYER, C.A., AUCOIN, J.M., and SMITH, F.I. (1996). Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Therapy 3, 437-447.
31. DRAZBA, I.A., and RALSTON, E. (1993). Expression of E. coli β-galactosidase in low density cultures of hippocampal neurons. Abstr. Neurosci. Soc. 718, 10.
32. DRAGHIA, R., CAILLAUD, C., MANICOM, R., PAVIRANI, A., KAHN, A., and POENARU, L. (1995). Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther. 2, 418-423.
33. DU, B., WU, P., BOLDT-HOULE, D.M., and TERWILLIGER, E.F. (1996). Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther. 3, 254-261.
34. EMERICH, D.F., HAMRNANG, J.P., BAETGE, E.E., and WINN, S.R. (1994). Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. 130, 141-150.
35. EVRARD, C., BORDE, I., MARIN, P., GALIANA, E., PREMONT, J., GROS, F., and ROUGET, P. (1990). Immortalization of bipotential and plastic glio-neuronal precursor cells. Proc. Natl. Acad. Sci. USA 87(8), 3062-3068.
36. FALLER, D.V., and BALTIMORE, D. (1984). Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J. Virol. 49(1), 269-272.
37. FANG, X.J., KEATING, A., DEVILLIERS, J., and SHERMAN, M. (1989). Tissue-specific activity of heterologous viral promoters in primary rat hepatocytes and Hep G2 cells. Hepatology 10(5), 781-787.
38. FARHOOD, H., GAO, X., SON, K., YANG, Y-Y., LAZO, J.S., and HUANG, L. (1995). Cationic liposomes for direct gene transferin therapy of cancer and other diseases. Ann. NY Acad. Sci. 716, 23-35.
39. FELGNER, P.L. (1993). Cationic lipid/polynucleotide condensates for in vitro and in vivo polynucleotide delivery the cytofectins. J. Lip. Res. 3(1), 3-16.
40. FELGNER, P.L. (1996). Improvements in cationic liposomes for in vivo gene transfer. Human Gene Ther. 7, 1791-1793.
41. FELGNER, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M., and Danielsen, M. (1987). Lipofection, A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Nalt. Acad. Sco. 84, 7413-7417.
42. FICK, J., and ISRAEL, M.A. (1994). Gene therapy for diseases of the nervous system. West J. Med. 161, 260-263.
43. FISCHER, W., BJORKLUND, A., CHEN, K., and GAGE, F.H. (1991). NGF improves spatial memory in aged rodents as a function of age. J. Neurosci. 11, 1889-1906.
44. FISCHER, W., and BJORKLUND, A. (1991). Loss of AchE and NGFr-labeling precedes neuronal death of axotomized septodiagonalband neurons: Reversal by intraventricular NGF infusion. Exp. Neurol. 113, 93-108.
45. FLOTTE, T.R., and CARTER, B.J. (1995). Adeno-associated virus vectors for gene therapy. Gene Ther. 2, 357-362.
46. FREESE, A., GELLER, A.I., and NEVE, R. (1990). HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology. Biochem. Pharmacol. 40, 2189-2199.
47. FRIEDMANN, T., and JINNAH, H.A. (1993). TIB tech 11, 156-162.
48. FROMM, M., TAYLOR, L.P., and WALBOT, V. (1985). Expression of genes transferred into monocot and dicot plant cells by electroporation. Proc. Natl. Acad. Sci. USA 82, 5824-5828.
49. GAO, X., and HUANG, L. (1993a). Cationic liposomes and polymers for gene transfer. J. Liposome Res. 3, 17-30.
50. GAO, X., and HUANG, L. (1993b). Cytoplasmic expression of a reporter gene by co-delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes. Nucl. Acids Res. 21, 2867-2872.
51. GAO, X., and HUANG, L. (1995). Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722.
52. GINSBERG, H.S. (1996). The up and downs of adenovirus vectors. Bull N.Y. Acad. Med. 73(1), 53-58.
53. GIORDANO, T., PAN, J.B., CASUTO, D., WATANTE, S., and ARNERIC, S.P. (1992). Thyroid hormone regulation of NGF, NT-3 and BDNF RNA in the adult rat brain. Mol. Brain Res. 16, 239-245.
54. GIORDANO, T., HOWARD, T.H., COLEMAN, J., SAKAMOTO, K., and HOWARD, B.H. (1991). Isolation of a population of transiently transfected quiescent and senescent cells by magnetic affinity cell sorting. Exp. Cell Res. 992, 993-997.
55. GOTTSCHALK, S., CRISTIANO, R.J., SMITH, L.C., and WOO, S.L.C. (1993). Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther. 1, 165-191.
56. GRAHAM, F.L., and VANDEREB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
57. GREENE, L.A., and TISCHLER, A.S. (1982). PC12 pheochromocytoma cultures in neurobiological research. Adv. Cell Neurobiol. 3, 373-414.
58. HADDADA, H., CORDIER, L., and PERRICAUDET, M. (1995). Gene therapy using adenovirus vectors. Curr. Top. Microbiol. Immunol. 199 (pt 3), 297-306.
59. HAGG, T., VAHLSING, L.H., MANTHORPE, M., and VARON, S. (1990). Nerve growth factor infusion into the denervated adult rat hippocampal formation promotes its cholinergic reinnervation. J. Neurosci. 10(9), 3087-3092.
60. HAWLEY-NELSON, P., et al. (1993). LipofectAMINE™ reagent: A new, higher efficiency polycationic liposome transfection reagent. Focus 15, 73-79.
61. HAYES, R.L., JENKINS, L.W., and LYETH, B.G. (1991). Neurotransmitter mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. Central Nervous System Status Report: 1991. J. Neurotrauma 9, s173-s178.
62. HAYES, R.L., YANG, K., WHITSON, J.S., XUE, J.J., KAMPFL, A., MU, X.S., ZHAO, X., FAUSTTNELLA, F., and CLIFTON, G.L. (1995). Rescue of injury-induced loss by BDNF gene transfection in primary septo-hippocampal cell cultures. Neurosci. Lett. 191, 121-125.
63. HEATH, T.D., LOPEZ, N.G., PIPER, J.R., MONTGOMERY, J.A., STERN, W.H., and PAPAHADJOPOLOUS, D. (1986). Liposome-mediate delivery of pteridine antifolates to cells in vitro: potency of methotrexate, and its a and y substituents. Biochem. Biophys. Acta 862, 72-80.
64. HEFTI, F. (1986). Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 8, 2155-2162.
65. HEISTAD, D.D., and FARACI, M.F. (1996). Gene therapy for cerebral vascular disease. Stroke 27(9), 1688-1693.
66. HOLT, C.E., GARLICK, N., and CORNEL, E. (1990). Lipofection of cDNAs in the embryonic vertebrae central nervous system. Neuron 4, 203-214.
67. HUANG, Q., VONSATTEL, J.P., SCHAFFER, P.A., MARTUZA, R.L., BREAKEFIELD, X.O., and DIFIGLIA, M. (1992). Introduction of a foreign gene (E. coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: A light and electron microscopic study. Exp. Neurol. 115, 303-316.
68. HUG, P., and SLEIGHT, R.G. (1991). Liposomes for the transformation of eukaryotic cells. Biochem. et Biophys. Acta 1097, 1-17.
69. IMAIZUMI, S., WOOLWORTH, V., FISHRNAN, R.A., and CHAN, P.K. (1990). Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 21, 1312-1317.
70. IP, N.Y., LI, Y., YANCOPOULOS, G.D., and LINDSAY, R.M. (1993). Cultured hippocampal neurons show response to BDNF, NT-3 and NT4, but not NGF. J. Neurosci. 13, 3394-3405.
71. ISHII, K., INOUE, H., HAKURA, A., ARAKI, W., and MASUDA, T. (1992). Immortalization of fetal mouse brain glial cells by human papillomavirus type 16 E7 genes. Cell Struct. Func. 17(3), 197-202.
72. IWAMOTO, Y., YANG, K., MU, X.S., XUE, J.J., CLIFTON, G.L., and HAYES, R.L. (1996). BDNF cDNA following liposome-mediated gene transfer in intact and traumatically injured rat brain. NeuroReport 7, 609-612.
73. JIAO, S., ACSADI, G., JANI, A., FEIGNER, P., and WOLFF, J. (1992). Persistence of plasma DNA and expression in rat brain cells in vivo. Exp. Neurol. 115, 400-413.
74. JOHNSON, P.A., YOSHIDA, K., GAGE, F.H., and FRIEDMANN, T. (1992). Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol. Brain Res. 12, 95-102.
75. KARPATI, G., LOCHMULLER, H., NALBANTOGLU, J., and DURHAM, H. (1996). The principles of gene therapy for the nervous system. TINS 19(2), 49-54.
76. KATO, K., NAKANISHI, M., KANEDA, Y., UCHIDA, T., and OKADA, Y. (1991). Expression of hepatitis B virus surface antigen in adult rat liver: Co-introduction of DNA and nuclear protein by a simplified liposome method. J. Biol. Chem. 266(6), 3361-3364.
77. KAWAJA, M.D., ROSENBERG, M.B., YOHIDA, K., and GAGE, F.H. (1992). Somatic gene transfer of nerve growth factors promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J. Neurosci. 12, 2849-2864.
78. KIM, D.H., GUTIN, P.H., NOBLE, L.J., NATHAN, D., YU, J.S., and NOCKELS, R.P. (1996). Treatment with genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat. NeuroReport 7, 2221-2225.
79. KOTIN, R.M. (1994). Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5, 793-801.
80. KROMER, L.F. (1987). Nerve growth factor treatment after brain injury prevents neuronal death. Science 235, 215-216.
81. LASIC, D.D., and PAPAHADJOPOULOS, D. (1995). Liposomes revisited. Science 267, 1275-1276.
82. LAWRENCE, M., SUN, G.H., KUNIS, D.M., SAYDARN, T.C., DASH, R., HO, D.Y., SAPOLSKY, R.M., and STEINBERG, G.K. (1996). Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J. Cereb. Blood Flow Metab. 16(2), 181-185.
83. LE, W., YANG, K., WHITSON, J.S., CLIFTON, G.L., and HAYES, R.L. (1996). Liposome-mediated NGF gene transfection increases ChAT activity in rat septo-hippocampal cell cultures. NeuroReport 7, 710-712.
84. LEE, R.J., and HUANG, L. (1996). Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell specific gene transfer. Biochemistry 35, 1027-1036.
85. LEDLEY, F.D. (1995). Non-viral gene therapy: The promise of genes as pharmaceutical products. Human Gene Ther. 6, 1129-1144.
86. LE GAL LA SALLE, G., ROBERT, J.J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
87. LI, A.P., MYER, C.A., and KAMINSKI, D.L. (1992). Gene transfer in primary cultures of human hepatocytes. In Vitro Cell Dev. Biol. 28A, 373-375.
88. LIU, Y., LIGGITT, D., ZHONG, W., TU, G., GAENSLER, K., and DEBS, R. (1995). Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. 270, 24864-24870.
89. LOPEZ-BERESTEIN, G., FAINSTEIN, V., HOPFER, R., MEHTA, K., SULLIVAN, M.P., KEATING, M., ROSENBLUM, M.G., MEHTA, R., LUNA, M., HERSH, E.M., REUBEN, J., JULIANO, R.L., and BODEY, G.P. (1985). Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study. J. Inf. Dis. 151(4), 704-710.
90. LUCIDI-PHILLIPI, C.A., GAGE, F.H., SHULTS, C.W., JONES, K.R., REICHARDT, L.F., and KANG, U.J. (1995). Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain. J. Comp. Neurol. 354, 361-376.
91. LYCKE, E., HAMARK, B., JOHANSSON, M., KROTOCHWIL, A., LYCKE, J., and SVENNERHOLM, B. (1988). Herpes simplex virus infection of the human sensory neuron: An electron microscopy study. Arch. Virol. 101, 87-104.
92. McDERMONT, K.L., RAGHUPATHI, R., FERNANDEZ, S.C., SAATMAN, K.E., PROTTER, A.A., FINKLESTEIN, S.P., SMITH, D.H., and MCINTOSH, T.K. (in press). Delayed administration of basic fibroblast growth factor attenuates cognitive dysfunction following lateral fluid percussion brain injury in the rat. J. Neurochem.
93. MICKLUS, M., GREEIG, N., TUNG, J., and RAPOPORT, S.I. (1992). Organ distribution of liposomal formulations following intracarotid infusion in rats. Biochim. et Biophys. Acta 1124, 7-12.
94. MORI, N., and FUKATSU, T. (1992). Anticonvulsant effect of DN-1417, a derivative of thyrotropin-releasing hormone, and liposome entrapped DN-1417, on amygdaloid-kindled rats. Epilepsia 33(6), 994-1000.
95. MORSE, J.K., WIEGAND, S.J., ANDERSON, K., YOU, Y., CAL, N., CARNAHAN, J., MILLER, J., DISTEFANO, P.S., ALTAR, C.A., LINDSAY, R.M., and ALDERSON, R.F. (1993). Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J. Neurosci. 13(10), 4146-4156.
96. MULLER, S.R., SULLIVAN, P.D., CLEGG, D.O., and FEINSTEIN, S.C. (1990). Laboratory methods: Efficient transfection and expression of heterologous genes in PC 12 cells. DNA Cell Biol. 9(3), 221-229.
97. NABEL, E.G., GORDON, D., YANG, Z.Y., XU, L., SAN, H., PLAUTZ, G.E., WU, B.Y., GAO, ., HUANG, L., and NABEL, G.J. (1992a). Gene transfer in vivo with DNA liposome complexes: lack of autoimmunity and gonadal localization. Human Gene Ther. 3(6), 649-656.
98. NABEL, G.J., CHANG, A., NABEL, E.G., PLAUTZ, G.E., FOX, B.A., HUANG, L., and SHU, S. (1992b). Immunotherapy of malignancy by in vivo gene transfer into tumors. Human Gene Ther. 3, 17-30.
99. NABEL, G.L. (1993). Direct gene transfer with DNA liposome complexes in melanoma: expression, biological activity, lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11307-11311.
100. ONO, T., FUJINO, Y., TSUCHIYA, T., and TSUDA, M. (1990). Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci. Lett. 117, 259-263.
101. PIKUL, S.S.II, PARKS, N.J., and SCHNEIDER, P.D. (1987). In vitro killing of melanoma by liposome-delivered intracellular irradiation. Arch. Surg. 122, 1417-1420.
102. RADLER, J.O., KOLTOVER, I., SALDITT, T., and SAFINYA, C.R. (1997). Structure of DNA-cationic liposome complexes DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275, 810-814.
103. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53(1), 83-88.
104. ROESSLER, B., and DAVIDSON, B.L. (1994). Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. Neuroscience Lett. 167, 5-10.
105. ROSENBERG, M.B., FRIEDMANN, T., ROBERTSON, R.C., TUSZYNSKI, M., WOLFF, J.A., BREAKEFIELD, X.O., and GAGE, F.H. (1988). Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242, 1575-1578.
106. RYLETT, R.J., GODDARD, S., SCHMIDT, B.M., and WILLIAMS, L.R. (1993). Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. J. Neurosci. 13(9), 3956-3963.
107. SCALI, C., CASAMENTI, F., PAZZAGLI, M., BARTOLINI, L., and PEPEU, G. (1994). Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. Neurosci. Lett. 170, 117-120.
108. SCHOFIELD, J.P., and CASKEY, C.T. (1995). Non-viral approaches to gene therapy. Brit. Med. Bull. 51, 56-71.
109. Science news (1995).: NIH picks three gene vector centers. Science 269, 751.
110. SINGHAL, A., and HUANG, L. (1994). Direct gene transfer by liposomes. J. Liposome Res. 4, 289-299.
111. SINSON, G., VODDI, M., and MCINTOSH, T.K. (1995). Nerve growth factor administration attenuates cognitive but not neurobehavioral motor dysfunction or hippocampal cell loss following fluid-percussion brain injury in rats. J. Neurochem. 65, 2209-2216.
112. SINSON, G., VODDI, M., and MCINTOSH, T.K. (1996). Combined fetal neural transplantation and nerve growth factor infusion: Effects on neurological outcome following fluid-percussion brain injury in the rat. J. Neurosurgery 84, 665-662.
113. SMITH, A.E. (1995). Viral vectors in gene therapy. Annu. Rev. Microbiol. 49, 807-838.
114. STEWART, M.J., PLAUTZ, G.F., DEL-BUONO, L., YANG, Z.Y., XU, L., GAO, X., HUANG, L., NABEL, E.G., and NABEL, G.J. (1992). Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Human Gene Ther. 3, 267-275.
115. STORM, G., STEERENBERG, P.A., VANBORSSUM-WALKES, M., EMMEN, F., and CROMMELIN, D.J.A. (1988). Potential pitfalls in in vitro antitumor activity testing of free and liposome-entrapped doxorubicin. J. Pharm. Sci. 77(10), 823-830.
116. SUHR, ST., and GAGE, F.H. (1993). Gene therapy for necrologic disease. Arch. Neural. 50, 1252-1268.
117. TAMIYA, T., WEI, M.X., CHASE, M., ONO, Y., LEE, F., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1995). Transgene inheritance and retroviral infection contribute to the efficiency of gene expression in solid tumors inoculated with retroviral vector producer cells. Gene Ther. 2, 531-538.
118. THOMPSON, T.A., GOULD, M.N., BURKHOLDER, J.K., and YANG, N.S. (1993). Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cell Dev. Biol. 29A, 165-170.
119. TOMITA, N., HIGAKI, J., KANEDA, Y., and OGIHARA, T. (1992). Direct in vivo gene introduction into rat kidney. Nippon-Rinsho 50(12), 2874-2878.
120. TUSZYUSKI, M.H., PETERSON, D.A., RAY, J., BAIRD, A., NAKAHARA, Y., and GAGE, F.H. (1994). Fibroblasts genetically modified to produced nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp. Neurol. 126, 1-14.
121. TUSZYNSKI, M.H., GABRIEL, K., GAGE, F.H., SHUR, S., MEYER, S., and ROSETTI, A. (1996a). Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury. Exp. Neurol. 137, 157-173.
122. TUSZYUSKI, M.H., ROBERTS, J., SENUT, M-C., U. H-S., and GAGE, F.H. (1996b). Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Therapy 3, 305-314.
123. VITIELLO, L., CHONN, A., WASSERMAN, J.D., DUFF, C., and WORTON, R.G. (1976). Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Therapy 3, 396-404.
124. WAGNER, E., PLANK, C., ZATLOUKAL, K., COTTEN, M., and BIRNSTIEL, M. (1992). Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylyusiube DNA complexes: toward a synthetic cirus like gene transfer vehicle. Proc. Natl. Acad. Sci. USA 89, 7934-7938.
125. WHITSON, J.S., KAMPFL, A., ZHAO, X., DIXON, C.E., and HAYES, R.L. (1995). Brief potassium depolarization decreases neurofilarnent proteins in CNS culture. Brain Res. 694, 213-222.
126. WILLIAMS, L.R., VARON, S., PETERSON, G.M., WICTORIN, K., FISCHER, W., BJORKLUND, A., and GAGE, F.H. (1986). Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc. Natl. Acad. Sci. USA 83, 9231-9235.
127. WILSON, T., PAPAHADJOPOLOUS, D., and TABER, R. (1977). Biological properties of polivirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc. Natl. Acad. Sci. USA 74(8), 3471-3475.
128. WILSON, T., PAPAHADJOPOLOUS, D., and TABER, R. (1979). The introduction of poliovirus RNA into cells via lipid vesicles (liposomes). Cell 17, 77-84.
129. WINN, S.R., HAMMANG, J.P., EMERICH, D.F., LEE, A., PALMITER, R.D., and BAETGE, E.E. (1994). Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. USA 91, 2324-2328.
130. WOLF, D., RICHTER-LANDSBERG, C., SHORT, M.P., CEPKO, C., and BREAKEFIELD, X.O. (1988). Retrovirus mediated gene transfer of β-nerve growth factor into mouse pituitary line AtT-20. Mol. Biol. Med. 5, 43-49.
131. WONG, T.K., and NEUMANN, E. (1982). Electric field mediated gene transfer. Biochem. Biophys. Res. Commun. 107(2), 584-587.
132. WU, G.Y., WINSON, J.M., SHALABY, F., GROSSMAN, M., SHAFRITZ, D.A., WU, C.H. (1991). Receptor-mediated gene delivery in vivo: partial correction of genetic analbuminemia in Nagase rats. J. Biol. Chem. 266, 14338-14342.
133. YAMADA, M., SHIMIZU, K., MIYAO, Y., HAYAKAWA, T., IKENAKA, K., NAKAHIRA, K., NAKAJlMA, K., KAGWA, T., and MIKOSHIBA, K. (1992). Retrovirus-mediated gene transfer targeted to malignant glioma cells in murine brain. Jap. J. Cancer Res. 83(12), 1244-1247.
134. YANG, K., FAUSTINELLA, F., XUE, J.J., WHITSON, J.S., KAMPFL, A., MU, S., ZHAO, X., TAGLIALATELA, G., PEREZ-POLO, J.R., CLIFTON, G.L., and HAYES, R.L. (1994a). Optimizing liposome-mediated gene transfer in primary rat septo-hippocampal cell cultures, Neurosci. Lett. 182, 287-290.
135. YANG, K., FAUSTINELLA, F., XUE, J.J., WHITSON, J.S., KAMPFL, A., MU, X.S., ZHAO, X., TAGLIALATELA, G., PEREZ-POLO, J.R., CLIFTON, G.L., and HAYES, R.L. (1994b). Sustained expression of functional nerve growth factor in primary septohippocampal cell cultures by liposome-mediated gene transfer. Neurosci. Lett. 182, 291-294.
136. YANG, K., PEREZ-POLO, J.R., FAUSTINELLA, F., TAGLIALATELA, G., and HAYES, R.L. (1995b). In vitro studies of liposome-mediated gene transfection, in Paradigms in Neural Injury. J.R. Perez-Polo (ed.). Academic Press: San Diego, pp. 290-297.
137. YANG, K., XUE, J.J., WHITSON, J.S., KAMPFL, A., ZHAO, X., IWAMOTO, Y., MU, X.S., FAUSTINELLA, F., CLIFTON, G.L., and HAYES, R.L. (1996). Liposome-mediated NGF gene transfection increases phosphorylated neurofilament proteins. Mol. Brain Res. 43, 13-20.
138. YANG, K., BIAN-XUE, J.J., MU, X.S., QIU, Y., PEREZ-POLO, J.R., CLIFTON, G.L., and HAYES, R.L. (in preparation). Liposome-mediated NGF gene transfection recover the neurofilament and ChAT loss.
139. YANG, N.S., BURKHOLDER, J., ROBERTS, B., MARTINELL, B., and MCCABE, D. (1990). In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568-9572.
140. ZHANG, L.X., WU, M., and HAN, J.S. (1992). Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vector. NeuroReport 3, 700-702.
141. ZHANG, L.X., LI, X.L., SMITH, M.N., POST, R.M., and HAN, J.S. (1997). Lipofectin-facilitated transfer of cholecystokinin gene corrects behavioral abnormalities of rats with audiogenic seizures. Neuroscience 77(1), 15-22.
142. ZHOU, X., KLIBANOV, A., and HUANG, L. (1992). Improved encapsulation of DNA in pH-sensitive liposomes for transfection. J. Liposome Res. 2(1), 125-139.
143. ZHU, J., ZHANG, L., HANISCH, U.K., FELGNER, P.L., and RESZKA, R. (1996). A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene Therapy 3, 472-476.
144. ZHU, N., LIGGITT, D., LIU, Y., and DEBS, R. (1993). Systemic gene expression after intravenous DNA delivery into adult mice. Science 261, 209-211.